by Nathalie OLOF-ORS Agence France-Presse ZURICH, Switzerland (AFP) -US pharmaceuticals giant Johnson & Johnson on Thursday announced it was buying Europe’s biggest bio-pharmaceutical firm Actelion for $30 billion (27.9 billion euros) in a deal that creates a new spin-off company. The world’s biggest producer of healthcare goods will acquire all the outstanding shares of Switzerland-based Actelion for $280 per share, the two companies said in a joint statement. With the deal, which has been approved […]